SFM
Sphera Funds Management Portfolio holdings
AUM
$382M
This Quarter Return
-10.97%
1 Year Return
+0.41%
3 Year Return
+99.29%
5 Year Return
+177.09%
10 Year Return
+575.73%
AUM
$405M
AUM Growth
+$405M
(-25%)
Cap. Flow
-$58.7M
Cap. Flow
% of AUM
-14.49%
Top 10 Holdings %
Top 10 Hldgs %
35.11%
Holding
122
New
18
Increased
18
Reduced
51
Closed
9
Top Buys
| 1 |
Mineralys Therapeutics
MLYS
|
$4.36M |
| 2 |
Nova
NVMI
|
$4.16M |
| 3 |
MAZE
Maze Therapeutics, Inc. Common Stock
MAZE
|
$3.91M |
| 4 |
Sarepta Therapeutics
SRPT
|
$3.77M |
| 5 |
Syndax Pharmaceuticals
SNDX
|
$3.47M |
Top Sells
| 1 |
BridgeBio Pharma
BBIO
|
$18.6M |
| 2 |
Microsoft
MSFT
|
$6.66M |
| 3 |
Meta Platforms (Facebook)
META
|
$6.36M |
| 4 |
Check Point Software Technologies
CHKP
|
$6.22M |
| 5 |
Acadia Pharmaceuticals
ACAD
|
$5.29M |
Sector Composition
| 1 | Healthcare | 78.9% |
| 2 | Technology | 13.54% |
| 3 | Consumer Discretionary | 2.19% |
| 4 | Communication Services | 2.14% |
| 5 | Utilities | 1.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Salesforce
CRM
$245B
| $2.44M | 0.56% |
+9,100
| New | +$2.44M |
|
52
Biohaven
BHVN
$1.71B
| $2.4M | 0.55% |
99,784
-56,710
| -36% | -$1.36M |
|
53
enGene Holdings
ENGN
$249M
| $2.37M | 0.55% |
528,365
-31,635
| -6% | -$142K |
|
54
Skye Bioscience
SKYE
$104M
| $2.35M | 0.54% |
1,476,353
-88,275
| -6% | -$140K |
|
55
Workday
WDAY
$62.3B
| $2.34M | 0.54% |
10,000
| – | – |
|
|
SWTX
56
DELISTED
SpringWorks Therapeutics
SWTX
| $2.3M | 0.53% |
52,009
-47,991
| -48% | -$2.12M |
|
57
Pfizer
PFE
$141B
| $2.28M | 0.53% |
90,000
| – | – |
|
58
Kura Oncology
KURA
$732M
| $2.27M | 0.52% |
343,522
-266,565
| -44% | -$1.76M |
|
59
Enliven Therapeutics
ELVN
$1.24B
| $2.2M | 0.51% |
+111,743
| New | +$2.2M |
|
60
Tower Semiconductor
TSEM
$6.96B
| $2.19M | 0.51% |
61,549
-104,600
| -63% | -$3.73M |
|
61
Uber
UBER
$194B
| $2.19M | 0.5% |
30,000
| – | – |
|
62
Alphabet (Google) Class C
GOOG
$2.79T
| $2.11M | 0.49% |
13,500
-30,000
| -69% | -$4.69M |
|
63
Viking Therapeutics
VKTX
$3.02B
| $2.01M | 0.46% |
83,270
-20,000
| -19% | -$483K |
|
64
Cogent Biosciences
COGT
$1.83B
| $2.01M | 0.46% |
+335,024
| New | +$2.01M |
|
65
VistaGen Therapeutics
VTGN
$113M
| $1.98M | 0.46% |
790,550
-18,000
| -2% | -$45K |
|
66
Broadcom
AVGO
$1.42T
| $1.96M | 0.45% |
11,695
-5,185
| -31% | -$868K |
|
67
Ionis Pharmaceuticals
IONS
$9.64B
| $1.93M | 0.44% |
63,821
| – | – |
|
68
Nike
NKE
$110B
| $1.91M | 0.44% |
+30,050
| New | +$1.91M |
|
|
69
Check Point Software Technologies
CHKP
$20.6B
| $1.9M | 0.44% |
8,334
-27,301
| -77% | -$6.22M |
|
70
Rocket Pharmaceuticals
RCKT
$358M
| $1.81M | 0.42% |
271,792
| – | – |
|
|
71
Microsoft
MSFT
$3.76T
| $1.72M | 0.4% |
4,592
-17,735
| -79% | -$6.66M |
|
72
Nutrien
NTR
$27.6B
| $1.53M | 0.35% |
30,894
-25,000
| -45% | -$1.24M |
|
73
Structure Therapeutics
GPCR
$1.14B
| $1.45M | 0.33% |
+84,000
| New | +$1.45M |
|
74
WIX.com
WIX
$8.05B
| $1.44M | 0.33% |
8,800
-30,453
| -78% | -$4.98M |
|
75
JFrog
FROG
$5.58B
| $1.37M | 0.32% |
42,871
-147,510
| -77% | -$4.72M |
|